Noumi Limited · ASX:NOU
Noumi — Shareholder Meeting (November 2025)
28 slides from Noumi's shareholder meeting presentation, Nov 6, 2025
Slide 1: 2025 Annual General Meeting Presentation and Addresses
Noumi Limited 8a Williamson Road Ingleburn NSW 2565 Australia ABN 41 002 814 235 6 November 2025 ASX Market Announcements ASX Limited Exchange Centre 20 Bridge Street Sydney NSW 2000 2025 Annual General Meeting Presentation and Addresses Noumi Limited (ASX: NOU) provides the following documents for
Slide 2: 2025 Annual General Meeting
Noumi Limited 2025 Annual General Meeting 6 November 2025
Slide 3: Important notice and disclaimer
Important notice and disclaimer Summary Information Only This presentation criteria contains general information about Noumi Limited and its consolidated entities (“Noumi Limited”) and its activities current as at the date of this presentation. It is provided in summary and does not purport to be co
Slide 4: Noumi – Key manufacturing sites
Noumi – Key manufacturing sites Dairy & Nutritionals Plant-based Milks Shepparton, VIC Ingleburn, NSW • Noumi Nutritionals is a leading Australian • Our state-of-the-art facility in Ingleburn, manufacturer of quality Long-life dairy New South Wales specialises in the products and premium protein dev
Slide 5: Our Business Units
Our Business Units
Slide 6: Our Brands
Noumi has a broad portfolio of strong Our Brands brands that meet differing consumer needs and occasions across multiple markets.
Slide 7: Introduction
Introduction Chair: Genevieve Gregor Noumi Limited | 2025 Annual G eneral Meeting
Slide 8: Agenda
Agenda INTRODUCTION 01 CHAIR’S ADDRESS 02 CEO’S ADDRESS 03 FORMAL BUSINESS 04 CLOSING REMARKS 05 Noum Limited | 2025 Annual General Meeting 7
Slide 9: Chair’s Address
Chair’s Address Genevieve Gregor Noumi Limited | 2025 Annual G eneral Meeting
Slide 10: FY25 operational progress
FY25 operational progress Adjusted operating EBITDA up 13% on FY24 Milklab 10-years old, generates $144m of revenue in FY25 International Plant-based revenue up 19% Dairy & Nutritionals doubles EBITDA1 from FY24 Legacy matters closed 1 Adjusted operating EBITDA Noumi Limited | 2025 Annual G eneral M
Slide 11: Key Achievements create a platform for the Future
Key Achievements create a platform for the Future Positioned at the intersection of consumer megatrends Growth opportunities close to the core Dairy improvements and closure of legacy matters allows for accelerated investment in our brands Alternatives for Convertible Note maturity being progressed
Slide 12: The Healthier Tomorrow Plan
The Healthier Imagining a Healthier Tomorrow is Noumi’s strategic Tomorrow Plan purpose and our guiding light as we seek to create a positive impact by promoting: For our consumers Through our farmers For our people & communities & production processes & stakeholders These Principles are the foundat
Slide 13: CEO’s Address
CEO’s Address Michael Perich Noumi Limited | 2025 Annual G eneral Meeting
Slide 14: Financial Highlights
FINANCIAL HIGHLIGHTS $57.4m $11.1m $50.3m Adj Op EBITDA 1,2 Dairy & Nutritionals Adj Op EBITDA 1 Plant-based Milks Adj Op EBITDA 1 $6.6m $5.6m $0.9m $595.8m $413.8m $182.0m Net Revenue Dairy & Nutritionals Net Revenue Plant-based Milks Net Revenue $6.0m $1.6m $4.4m ($150.0m) Statutory net loss after
Slide 15: Strategy
Strategy Noumi Limited | 2025 Annual G eneral Meeting
Slide 16: FY25 – A year of success
FY25 – A year of success Record revenue and EBITDA 1 in Plant-Based milks Retail expansion and market leadership Continued product innovation and category leadership Strategic international expansion across Asia Third year of improvement for Dairy and Nutritionals – EBITDA1 doubles YoY 1 Adjusted op
Slide 17: Strategy shifting to growth
Strategy shifting to growth Operational improvements support growth plans Maintain laser focus on execution Innovation in brands, marketing and formats Innovation in food science and technologies including AI Strategic opportunities close to the core Noumi Limited | 2025 Annual G eneral Meeting
Slide 18: Our Growth Strategy
Our Growth Strategy Develop high quality and innovative dairy and plant products to meet the different nutrition and taste needs of customers and consumers across life stages Strategic BARISTA’S RETAIL INTERNATIONAL DAIRY AND FUTURE GROWTH Pillars CHOICE CHANNEL MARKETS NUTRITIONALS PLATFORMS Champi
Slide 19: Formal Business
Formal Business Noumi Limited | 2025 Annual G eneral Meeting
Slide 20: Q&A
Q&A Noumi Limited | 2025 Annual G eneral Meeting
Slide 21: Imagining a healthier tomorrow
noum:. Imagining a healthier tomorrow
Slide 22: Noumi Ltd 2025 AGM Chair and CEO Addresses
Noumi Ltd 2025 Annual General Meeting Chair and CEO Addresses Ladies and Gentlemen, good morning. It is now 11:00am and I have been informed by the Company Secretary that a quorum is present and so I declare the 2025 Annual General Meeting of shareholders of Noumi Limited open. My name is Genevieve
Slide 23: Board remains committed to maintaining a majority of independent directors
As I have indicated in prior AGMs, the Board remains committed to maintaining a majority of independent directors on the Board, including an independent Chair. You will also be asked to vote today on resolutions to approve the Equity Incentive Plan and the renewal of the proportional takeover provis
Slide 24: As our strategy turns to growth
As our strategy turns to growth we see attractive opportunities close to our core and we are already executing on them. In the HORECA channel we are leveraging the leadership in Milklab Almond to expand our reach and our range. For those who have not heard of HORECA, it is what we used to call ‘out
Slide 25: Board re-elections and ESG efforts
and Jane have been instrumental during the financial, operational and cultural rebuilding of the company over the past years. The stability and commitment of directors have been critical factors in the success of the transformation, and we believe Board continuity will send an important message to c
Slide 26: Turning to the highlights
Turning to the highlights, FY25 represented another year of solid progress against our strategy, with the key operating metrics moving consistently in the right direction. • Group revenue rose 1% to over $595.8 million and group EBITDA rose 13% to $57.4 million, with another record sales performance
Slide 27: This turnaround reflects an improving cost structure
This turnaround reflects an improving cost structure through operational excellence initiatives, shifting to value-add product mix and manufacturing efficiency gains from selective capital investments. While we do not expect this segment to match Plant-based Milks' margins, we are pleased with the r
Slide 28: We have clear pathways to grow
We have clear pathways to grow in our existing domestic channels in geographies and products. We can make Milklab a truly international brand. We can support our ambition with investments in brand, innovation and team. We are executing better with our customer, distributor and supplier partnerships.